Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Connors

Showing results (61-70 of 302) with videos related to

Pageof 31
Sort By:
Leukemia & Lymphoma|October 16, 2014
Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture CollectionLaura K Fogli, Michael E Williams, Joseph M Connors, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Prognostic factors in follicular lymphomaThomas Relander, Nathalie A Johnson, Pedro Farinha, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2013
Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experienceSarah N Hamilton, Elaine S Wai, King Tan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2010
Cost-effectiveness of the addition of rituximab to CHOP chemotherapy in first-line treatment for diffuse large B-cell lymphoma in a population-based observational cohort in British Columbia, CanadaKarissa M Johnston, Carlo A Marra, Joseph M Connors, et al.
Orbit (Amsterdam, Netherlands)|November 5, 2013
Comparison of American Joint Committee on Cancer TNM-based staging system (7th edition) and Ann Arbor classification for predicting outcome in ocular adnexal lymphomaSuryasnata Rath, Joseph M Connors, Peter J Dolman, et al.
Genes, Chromosomes & Cancer|March 6, 2003
Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysisValia S Lestou, Olga Ludkovski, Joseph M Connors, et al.
Cancer|January 19, 2012
Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: involved-field versus involved-node radiotherapyBelinda A Campbell, Joseph M Connors, Randy D Gascoyne, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 3, 2015
Lifetime physical activity and the risk of non-Hodgkin lymphomaTerry Boyle, Richard P Gallagher, Randy D Gascoyne, et al.
Blood|August 30, 2011
Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcomeKerry J Savage, Brian Skinnider, Mubarak Al-Mansour, et al.
Leukemia & Lymphoma|May 27, 2004
The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive casesWing Y Au, Douglas E Horsman, Randy D Gascoyne, et al.
Pageof 31

Showing results (61-70 of 302) with videos related to

Sort By:
Pageof 31
Leukemia & Lymphoma|October 16, 2014
Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture CollectionLaura K Fogli, Michael E Williams, Joseph M Connors, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Prognostic factors in follicular lymphomaThomas Relander, Nathalie A Johnson, Pedro Farinha, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2013
Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experienceSarah N Hamilton, Elaine S Wai, King Tan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2010
Cost-effectiveness of the addition of rituximab to CHOP chemotherapy in first-line treatment for diffuse large B-cell lymphoma in a population-based observational cohort in British Columbia, CanadaKarissa M Johnston, Carlo A Marra, Joseph M Connors, et al.
Orbit (Amsterdam, Netherlands)|November 5, 2013
Comparison of American Joint Committee on Cancer TNM-based staging system (7th edition) and Ann Arbor classification for predicting outcome in ocular adnexal lymphomaSuryasnata Rath, Joseph M Connors, Peter J Dolman, et al.
Genes, Chromosomes & Cancer|March 6, 2003
Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysisValia S Lestou, Olga Ludkovski, Joseph M Connors, et al.
Cancer|January 19, 2012
Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: involved-field versus involved-node radiotherapyBelinda A Campbell, Joseph M Connors, Randy D Gascoyne, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 3, 2015
Lifetime physical activity and the risk of non-Hodgkin lymphomaTerry Boyle, Richard P Gallagher, Randy D Gascoyne, et al.
Blood|August 30, 2011
Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcomeKerry J Savage, Brian Skinnider, Mubarak Al-Mansour, et al.
Leukemia & Lymphoma|May 27, 2004
The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive casesWing Y Au, Douglas E Horsman, Randy D Gascoyne, et al.
Pageof 31